𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of MUC1 and EGP40 in bone marrow and peripheral blood as a marker for occult breast cancer

✍ Scribed by X. Y. Zhong; S. Kaul; G. Bastert

Publisher
Springer
Year
2001
Tongue
English
Weight
28 KB
Volume
264
Category
Article
ISSN
0003-9128

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Comparison of the clinical significance
Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer
✍ Gro Wiedswang; Elin Borgen; Cecilie Schirmer; Rolf KΓ₯resen; Gunnar Kvalheim; Jah πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 385 KB πŸ‘ 1 views

## Abstract Immunocytochemical (ICC) detection of disseminated tumor cells (DTC) in bone marrow (BM) in early breast cancer is an independent prognostic factor. The significance of circulating tumor cells (CTC) in peripheral blood (PB) needs further exploration and comparison to DTC detection. PB a

Monoclonal antibodies for detection of o
Monoclonal antibodies for detection of occult carcinoma cells in bone marrow of breast cancer patients
✍ Georgiana Ellis; Marina Ferguson; Elaine Yamanaka; Robert B. Livingston; Allen M πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 645 KB

Metastases develop in 30% to 40% of patients with operable breast cancer. Investigators have reported on the detection of occult micrometastases in bone marrow using an antibody to epithelial membrane antigen (EMA) and have since reported prognostic significance for these antibody-detected cells. In